CompaniesAlmedica

Almedica

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

400

By Phase

PHASE3: 1

By Status

COMPLETED: 3UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details

Recent Trials

NCT05908422Lead Sponsor
The Alvision™ Interventional Cardiology Diagnostic Catheter Post Market Clinical Follow-up (PMCF) Study.
N/ACompleted
100 participants
Started: Jan 1, 2023 · Completed: May 15, 2023
NCT05904951Lead Sponsor
The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study
N/ACompleted
100 participants
Started: Dec 1, 2022 · Completed: Apr 30, 2023
NCT05965037Lead Sponsor
The FLUYDO NC Post Market Clinical Follow-up Study
N/ACompleted
100 participants
Started: Nov 1, 2022 · Completed: Jun 15, 2023
NCT02076516Lead Sponsor
Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL)
PHASE3Unknown
100 participants
Started: Oct 31, 2013 · Completed: May 31, 2015
Related Companies
Aptuit
acquired